The Leukaemia Research Group is headed by Professor Øystein Bruserud.
The research has a major focus on the hematological malignancy acute myeloid leukaemia (AML); an aggressive disease that can be cured only by intensive chemotherapy eventually in combination with stem cell transplantation. Our main research areas are:
- Biological and functional characterization of primary human AML cells and their interactions with stromal elements
- Experimental studies of efficiency and toxicity (especially immunotoxicity) of both new targeted therapies and already established therapeutic strategies in human AML.
Key collaborators at Haukeland University Hospital, Department of Medicine, Section for Hematology:
Consultant and Head of Department Aymen Bushra Ahmed
Consultant Tor Henrik Anderson Tvedt
Collaborator, Bergen University College:
Assistant Professor Elisabeth Ersvær
Assistant Professor Anita Ryningen
Key collaborators, Department of Biomedicine, University of Bergen:
Professor Frode Berven
Professor Frode Selheim
Professor Guro Lind, The Norwegian Cancer Hospital, University of Oslo, Norway.
Professor Tobias Gedde-Dahl, The National Hospital, University of Oslo, Norway.
Professor Stefan Rose-John, University of Kiel, Germany.
Scientist Frederic Pendino, Institut COCHIN Inserm U1016 - CNRS 8104 - Université Paris Descartes, Paris, France.